Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,683 | 125 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $702.75 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $377.74 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $210.98 | 14 | $0 (2024) |
| GENZYME CORPORATION | $173.78 | 9 | $0 (2024) |
| ABBVIE INC. | $156.15 | 8 | $0 (2024) |
| Optinose US, Inc. | $155.22 | 9 | $0 (2024) |
| kaleo, Inc. | $125.32 | 7 | $0 (2022) |
| CSL Behring | $121.00 | 5 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.73 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $80.66 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $946.10 | 37 | Regeneron Healthcare Solutions, Inc. ($252.79) |
| 2023 | $546.26 | 27 | Regeneron Healthcare Solutions, Inc. ($259.79) |
| 2022 | $820.95 | 40 | Regeneron Healthcare Solutions, Inc. ($152.31) |
| 2021 | $369.64 | 21 | Optinose US, Inc. ($68.48) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Cycle Pharmaceuticals Inc | Sajazir (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $21.29 | General |
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.48 | General |
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/26/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/30/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 208 | 261 | $27,480 | $8,503 |
| 2022 | 6 | 205 | 235 | $25,722 | $7,680 |
| 2021 | 5 | 173 | 224 | $25,657 | $7,887 |
| 2020 | 5 | 144 | 245 | $21,850 | $5,618 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 104 | $15,600 | $5,324 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $4,830 | $1,599 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,850 | $1,063 | 27.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 22 | 25 | $2,000 | $376.84 | 18.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 74 | 100 | $1,200 | $140.46 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 81 | $12,150 | $3,828 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $6,210 | $2,190 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,200 | $1,078 | 25.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 25 | 27 | $1,620 | $336.57 | 20.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 25 | 27 | $810.00 | $157.87 | 19.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 51 | 61 | $732.00 | $89.48 | 12.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 101 | $15,150 | $4,681 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 33 | $7,590 | $2,592 | 34.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 24 | 31 | $1,885 | $436.57 | 23.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 13 | 18 | $540.00 | $115.60 | 21.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 29 | 41 | $492.00 | $61.94 | 12.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 105 | $15,310 | $3,861 | 25.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $2,530 | $758.51 | 30.0% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 30 | 81 | $2,385 | $506.56 | 21.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 12 | 15 | $815.00 | $315.32 | 38.7% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 12 | 33 | $810.00 | $176.27 | 21.8% |
About Cristina Eddy, PA-C
Cristina Eddy, PA-C is a Physician Assistant healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1285101147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cristina Eddy, PA-C has received a total of $2,683 in payments from pharmaceutical and medical device companies, with $946.10 received in 2024. These payments were reported across 125 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,683).
As a Medicare-enrolled provider, Eddy has provided services to 730 Medicare beneficiaries, totaling 965 services with total Medicare billing of $29,689. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Charleston, WV
- Active Since 10/30/2018
- Last Updated 11/07/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1285101147
Products in Payments
- DUPIXENT (Biological) $854.31
- FASENRA (Biological) $251.39
- Xhance (Drug) $155.22
- TEZSPIRE (Biological) $150.51
- TRELEGY ELLIPTA (Drug) $147.19
- RINVOQ (Biological) $135.71
- AUVI-Q (Drug) $125.32
- Haegarda (Biological) $121.00
- XOLAIR (Drug) $80.66
- YUPELRI (Drug) $76.83
- ORLADEYO (Drug) $68.40
- NUCALA (Biological) $63.79
- EUCRISA (Drug) $63.46
- Xolair (Biological) $62.01
- EOHILIA (Drug) $54.37
- AirDuo Digihaler (Drug) $29.50
- CUVITRU (Biological) $28.36
- Sajazir (Drug) $26.21
- SPIRIVA RESPIMAT (Drug) $21.58
- OPZELURA (Drug) $16.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Charleston
Michael Overcash, Pa, PA
Physician Assistant — Payments: $168,472
Elizabeth Harding
Physician Assistant — Payments: $18,250
Whitney Putillion, Pa-C, PA-C
Physician Assistant — Payments: $12,684
Corin Jaynes, Pa, PA
Physician Assistant — Payments: $11,995
Karen Byrd, Pa-C, PA-C
Physician Assistant — Payments: $11,725
John Richey, Pa-C, PA-C
Physician Assistant — Payments: $11,621